# Rasuvo

NDC: 59137-535
Generic name: methotrexate
Labeler / Manufacturer: Medexus Pharma Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20140710

FDA application: NDA205776

## Active ingredients

- METHOTREXATE SODIUM: 22.5 mg/.45mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59137-535"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59137-535
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d0075461-0e7e-4967-9c9b-d6440e912c0e